Mexico Medical Device Regulatory Timeline 2025 to 2026

1. Key takeaways

In the seventeen months from April 2025 to August 2026, Mexico implemented six major changes affecting medical devices in succession: the replacement of the GMP standard, the restructuring of the low-risk list, the launch of the simplified pathway, the consolidation of application codes, the amendment of the General Health Law, and the replacement of the labelling standard together with the launch of the registration query system. This chronology is the foundation for scheduling and budgeting any Mexico programme, because every downstream plan inherits its dates from these events. The events also interact with each other: a filing that crosses one of these dates may fall under a different version of the rules than the team assumed when the project was first planned.

• Six major changes landed between April 2025 and August 2026.
• Two standards have separated publication and effective dates, with long lead times.
• Two changes are hard cutovers: the old equivalence routes stopped being accepted on 2025-10-06, and the 2008 label standard is repealed on the effective date of the new one.
• The law and the implementing regulation carry a time gap, with transition projects governed by the rules at submission.
• Two items remain pending: the 10-year renewal for foreign-manufactured devices, and phase two of the query system.

2. Legal basis

The chronology below arranges the ten key instruments in time order, with the essential points of each. Because the sequence interleaves NOMs, agreements, decrees, and administrative launches, the dates themselves carry compliance consequences and should be entered into the compliance calendar exactly as printed here.

3. Expert insights

Insight one: six changes in seventeen months is an unusual density. GMP, the classification list, the pathway, the codes, the law, and labelling landed one after another, and a company that reviews regulations only once a year will have missed several of these nodes in sequence. Quarterly review is therefore necessary, and each review should check whether supplementary documents have appeared since the last pass. The density also argues for assigning each date a named owner, so that no entry depends on a single person’s memory.

Insight two: three of the changes separate publication from effectiveness. NOM-241-SSA1-2025 (240 calendar days) and NOM-137-SSA1-2025 (360 calendar days, plus a further 180 calendar days) do not take effect on publication. Treating the publication date as the effective date leads directly to scheduling errors, which is why both dates and the sell-off deadline must be marked separately on the calendar. Label artwork, inventory plans, and dossier updates all inherit their milestones from these two entries.

Insight three: two of the changes are hard cutovers. On 2025-10-06 the old equivalence routes stopped being accepted, and the effective date of NOM-137-2025 repeals the 2008 version. Continuing the old practice after the cutover point leads to rejection rather than to a warning, so both dates function as hard boundaries for any project timeline. Any application drafted around the former equivalence arrangement should be restructured before filing rather than submitted in the old form.

Insight four: the law and the regulation carry a time gap. The LGS amendment decree came on 2026-01-15 and the RIS implementation on 2026-04-24. Projects spanning those three months must determine which version of the rules applies, and the transition provisions handle this by the time of submission, so the filing date itself becomes the legal fact to record.

Insight five: two items are still pending. The RIS amendment decree does not yet extend the 10-year renewal to foreign-manufactured devices, and the start date and conversion criteria for phase two of the registration query system have not been announced. Both remain pending verification, and both should sit in the tracked-items column of the compliance calendar rather than in the closed items.

4. Practical recommendations

• Enter the ten dates from the table above as anchors in the compliance calendar, and review quarterly for supplementary documents.
• For standards with separated publication and effective dates, mark the effective date and the sell-off deadline as distinct entries.
• Do not cite the old equivalence routes after October 2025, and do not use the 2008 label version after the effective date in 2027.
• For projects spanning January and April 2026, confirm the applicable version of the rules through the transition provisions.
• Track the two pending items: the renewal term for foreign-manufactured devices, and phase two of the query system.

5. Verification checklist

• □ The ten key dates are entered in the compliance calendar
• □ The effective date of NOM-241-SSA1-2025 is marked (240 calendar days)
• □ The effective date and sell-off period of NOM-137-SSA1-2025 are marked (360 + 180 calendar days)
• □ Confirmed that the old equivalence routes closed on 2025-10-06 are not in use
• □ The applicable version for projects crossing the amendment nodes is confirmed
• □ The two pending items are in the tracking list

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Mexican market. Our team manages COFEPRIS registrations and equivalence (equivalencia) reviews, coordinates third-party authorised centre routes, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com